From: Comorbidities in unclassifiable interstitial lung disease
Cluster 1: (Few comorbidities) n = 77 | Cluster 2: (Cardiovascular) n = 85 | Cluster 3: (Emphysema) n = 87 | |
---|---|---|---|
Age, years (IQR) | 68.0 (57.0–75.0), p = 0.22 | 69.0 (58.0–75.0), p = 0.99 | 71.0 (61.0–77.0), p = 0.23 |
Male, % | 59.7, p = 0.91 | 63.5, p = 0.45 | 57.5, p = 0.51 |
Never smokers, % | 36.4, p = 0.78 | 37.8, p = 0.53 | 31.4, p = 0.37 |
Current smokers, % | 13.0, p = 0.53 | 12.2, p = 0.37 | 19.8, p = 0.13 |
Former smokers, % | 50.6, p = 0.86 | 50.0, p = 0.96 | 48.8, p = 0.83 |
Missing, % | 0.0 | 3.5 | 1.2 |
Pack years (IQR) | 20.0 (15.0–30.0), p = 0.18 | 25.5 (13.0–40.0), p = 0.47 | 35.0 (10.0–43.0), p = 0.56 |
Body mass index (SD) | 27.2 (5.3), p = 0.14 | 29.8 (4.9), p = 0.001† | 26.8 (4.8), p = 0.03* |
FVC, % predicted (SD) | 77.4 (21.3), p = 0.52 | 71.1 (26.4), p = 0.03* | 79.3 (24.8), p = 0.11 |
DLCO, % predicted (SD) | 53.8 (20.5), p = 0.06 | 44.5 (19.7), p = 0.006* | 51.6 (19.8), p = 0.36 |
6MWD, m (SD) | 377.7 (123.6), p = 0.19 | 304.2 (139.5), p < 0.0001* | 394.6 (127.2), p = 0.005† |
Total number of comorbidities, n (SD) | 0.9 (1.1), p < 0.0001* | 3.4 (2.0), p < 0.0001† | 2.0 (1.1), p = 0.41 |
Emphysema, % | 5.7, p < 0.0001* | 25.7, p = 0.01* | 70.3, p < 0.0001† |
Pulmonary hypertension, % | 3.9, p = 0.11 | 14.1, p = 0.01† | 5.7, p = 0.33 |
Venous thromboembolism, % | 3.9, p = 0.22 | 11.8, p = 0.03† | 4.6, p = 0.31 |
Sleep apnea, % | 2.6, p = 0.28 | 8.2, p = 0.07 | 3.4, p = 0.46 |
Coronary artery disease, % | 22.1, p = 0.14 | 28.2, p = 0.0005† | 1.1, p < 0.0001* |
Dyslipidemia, % | 6.5, p = 0.06 | 20.0, p = 0.009† | 10.3, p = 0.46 |
Arterial hypertension, % | 0.0, p < 0.0001* | 63.5, p < 0.0001† | 50.6, p = 0.008† |
Atrial fibrillation, % | 10.4, p = 0.46 | 7.1, p = 0.58 | 8.0, p = 0.87 |
Chronic heart failure, % | 7.8, p = 0.56 | 8.2, p = 0.40 | 3.4, p = 0.16 |
Heart valve disease, % | 3.9, p = 0.65 | 8.2, p = 0.07 | 2.3, p = 0.17 |
Cerebrovascular disease, % | 7.8, p = 0.69 | 3.5, p = 0.14 | 9.2, p = 0.28 |
Chronic renal failure, % | 1.3, p = 0.19 | 8.2, p = 0.005† | 1.1, p = 0.13 |
Diabetes, % | 0.0, p < 0.0001* | 55.3, p < 0.0001† | 0.0, p < 0.0001* |
Osteoporosis, % | 5.2, p = 0.22 | 8.2, p = 0.94 | 11.5, p = 0.20 |
Gastro-esophageal reflux disease, % | 0.0, p < 0.0001* | 51.8, p < 0.0001† | 2.3, p < 0.0001* |
Thyroid disease, % | 7.8, p = 0.56 | 9.4, p = 0.17 | 2.3, p = 0.05 |
Liver failure, % | 1.3, p = 0.56 | 0.0, p = 0.31 | 1.1, p = 0.66 |
Lung cancer, % | 0.0, p = 0.34 | 2.4, p = 0.049† | 0.0, p = 0.30 |
Cancer, % | 1.3, p = 0.03* | 4.7, p = 0.43 | 12.6, p = 0.003† |
Depression, % | 1.3, p = 0.01* | 7.1, p = 0.81 | 13.8, p = 0.007† |